Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
8.25
-0.15 (-1.79%)
Dec 20, 2024, 4:00 PM EST - Market closed

Zynex Revenue

Zynex had revenue of $49.97M in the quarter ending September 30, 2024, with 0.10% growth. This brings the company's revenue in the last twelve months to $193.67M, up 4.21% year-over-year. In the year 2023, Zynex had annual revenue of $184.32M with 16.54% growth.

Revenue (ttm)
$193.67M
Revenue Growth
+4.21%
P/S Ratio
1.38
Revenue / Employee
$176,059
Employees
1,100
Market Cap
262.73M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023184.32M26.16M16.54%
Dec 31, 2022158.17M27.87M21.39%
Dec 31, 2021130.30M50.18M62.63%
Dec 31, 202080.12M34.65M76.20%
Dec 31, 201945.47M13.56M42.47%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
Amylyx Pharmaceuticals 196.49M
Vanda Pharmaceuticals 190.86M
AC Immune 48.51M
C4 Therapeutics 33.67M
ProQR Therapeutics 20.51M
aTyr Pharma 235.00K
Sera Prognostics 94.00K
Revenue Rankings